Ambani Organics Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: July 31, 2024, 11:40 pm

Market Cap	70.6 Cr.
Current Price	100
High / Low	163/93.3
Stock P/E
Book Value	73.8
Dividend Yield	0.00 %
ROCE	2.12 %
ROE	5.39 %
Face Value	10.0
PEG Ratio	0.00

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Ambani Organics Ltd

Competitors of Ambani Organics Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Gujchem Distillers India Ltd	105 Cr.	294	541/73.3		390	0.00 %	1.38 %	2.17 %	1.00
Elantas Beck India Ltd	7,668 Cr.	9,672	14,980/8,150	54.9	1,094	0.05 %	23.0 %	17.4 %	10.0
Crestchem Ltd	68.5 Cr.	228	350/107	24.6	21.1	0.22 %	78.2 %	56.2 %	10.0
Chemiesynth (Vapi) Ltd	11.0 Cr.	35.8	34.1/0.00		37.5	0.00 %	1.00 %	3.38 %	10.0
Archit Organosys Ltd	81.8 Cr.	39.8	61.0/34.2	37.3	32.2	0.00 %	3.69 %	0.75 %	10.0
Industry Average	4,780.17 Cr	1,593.76		58.92	325.78	0.33%	15.97%	12.07%	7.41

All Competitor Stocks of Ambani Organics Ltd

Quarterly Result

Metric	Mar 2019	Sep 2019	Mar 2020	Sep 2020	Mar 2021	Sep 2021	Mar 2022	Sep 2022	Mar 2023	Sep 2023
Sales	42	38	36	26	61	67	59	67	66	62
Expenses	39	35	33	24	57	64	55	64	61	58
Operating Profit	3	3	3	2	4	3	4	4	5	5
OPM %	8%	7%	8%	9%	7%	5%	7%	5%	7%	7%
Other Income	-0	0	-0	0	0	0	0	0	-0	0
Interest	1	1	1	2	1	1	2	2	2	3
Depreciation	0	0	0	0	1	1	1	1	1	1
Profit before tax	1	1	1	0	2	1	2	1	2	0
Tax %	24%	42%	22%	24%	38%	32%	26%	26%	41%	70%
Net Profit	1	1	1	0	1	1	1	1	1	0
EPS in Rs	2.03	1.22	1.75	0.73	2.48	1.46	1.91	1.29	1.68	0.12

Last Updated: Unknown

Below is a detailed analysis of the quarterly data for Ambani Organics Ltd based on the most recent figures (Sep 2023) and their trends compared to the previous period:

For Sales, as of Sep 2023, the value is ₹62.00 Cr.. The value appears to be declining and may need further review. It has decreased from 66.00 Cr. (Mar 2023) to ₹62.00 Cr., marking a decrease of 4.00 Cr..
For Expenses, as of Sep 2023, the value is ₹58.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 61.00 Cr. (Mar 2023) to ₹58.00 Cr., marking a decrease of 3.00 Cr..
For Operating Profit, as of Sep 2023, the value is ₹5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2023) which recorded 5.00 Cr..
For OPM %, as of Sep 2023, the value is 7.00%. The value remains steady. There is no change compared to the previous period (Mar 2023) which recorded 7.00%.
For Other Income, as of Sep 2023, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2023) which recorded 0.00 Cr..
For Interest, as of Sep 2023, the value is ₹3.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.00 Cr. (Mar 2023) to ₹3.00 Cr., marking an increase of ₹1.00 Cr..
For Depreciation, as of Sep 2023, the value is ₹1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2023) which recorded 1.00 Cr..
For Profit before tax, as of Sep 2023, the value is ₹0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2.00 Cr. (Mar 2023) to ₹0.00 Cr., marking a decrease of 2.00 Cr..
For Tax %, as of Sep 2023, the value is 70.00%. The value appears to be increasing, which may not be favorable. It has increased from 41.00% (Mar 2023) to 70.00%, marking an increase of 29.00%.
For Net Profit, as of Sep 2023, the value is ₹0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1.00 Cr. (Mar 2023) to ₹0.00 Cr., marking a decrease of 1.00 Cr..
For EPS in Rs, as of Sep 2023, the value is 0.12. The value appears to be declining and may need further review. It has decreased from 1.68 (Mar 2023) to 0.12, marking a decrease of 1.56.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: Unknown

Metric	Mar 2011	Mar 2012	Mar 2013	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
Sales	14	21	27	33	52	65	79	73	87	125	132	129
Expenses	13	20	25	30	49	60	74	68	81	119	124	119
Operating Profit	1	1	2	3	3	5	6	5	6	6	8	10
OPM %	4%	4%	9%	8%	6%	7%	7%	7%	7%	5%	6%	7%
Other Income	0	0	0	-1	0	0	0	0	1	1	1	-0
Interest	0	0	1	2	2	2	3	3	3	3	4	5
Depreciation	0	0	0	0	0	1	1	1	1	1	1	2
Profit before tax	1	1	1	-0	1	2	2	2	3	3	3	2
Tax %	31%	32%	31%	-144%	31%	25%	27%	32%	36%	28%	35%
Net Profit	0	1	0	-0	1	2	2	2	2	2	2	1
EPS in Rs	5.47	3.03	1.78	-1.02	2.18	4.41	3.56	2.99	3.21	3.06	2.97	1.80
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2012-2013	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023
YoY Net Profit Growth (%)	-100.00%	100.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Change in YoY Net Profit Growth (%)	0.00%	200.00%	-100.00%	0.00%	0.00%	0.00%	0.00%

Ambani Organics Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 7 years from 2012-2013 to 2022-2023.

No data available for the compounded sales growth chart.

Balance Sheet

Last Updated: Unknown

Month	Mar 2011	Mar 2012	Mar 2013	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	1	2	3	4	4	4	5	5	5	6	6	13
Reserves	1	1	2	-0	0	2	11	12	14	24	26	39
Borrowings	3	6	10	13	13	16	15	20	34	53	72	55
Other Liabilities	4	7	8	14	22	26	31	26	25	29	33	68
Total Liabilities	9	15	23	30	38	48	62	63	78	112	137	176
Fixed Assets	1	2	3	9	10	10	11	12	19	20	19	64
CWIP	0	0	3	0	0	0	0	2	0	9	47	0
Investments	0	0	0	0	1	1	1	1	2	1	1	1
Other Assets	8	13	18	20	27	36	49	47	57	82	70	110
Total Assets	9	15	23	30	38	48	62	63	78	112	137	176

Below is a detailed analysis of the balance sheet data for Ambani Organics Ltd based on the most recent figures (Mar 2024) and their trends compared to the previous period:

For Equity Capital, as of Mar 2024, the value is ₹13.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹6.00 Cr. (Mar 2023) to ₹13.00 Cr., marking an increase of 7.00 Cr..
For Reserves, as of Mar 2024, the value is ₹39.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹26.00 Cr. (Mar 2023) to ₹39.00 Cr., marking an increase of 13.00 Cr..
For Borrowings, as of Mar 2024, the value is ₹55.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from ₹72.00 Cr. (Mar 2023) to ₹55.00 Cr., marking a decrease of 17.00 Cr..
For Other Liabilities, as of Mar 2024, the value is ₹68.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹33.00 Cr. (Mar 2023) to ₹68.00 Cr., marking an increase of 35.00 Cr..
For Total Liabilities, as of Mar 2024, the value is ₹176.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹137.00 Cr. (Mar 2023) to ₹176.00 Cr., marking an increase of 39.00 Cr..
For Fixed Assets, as of Mar 2024, the value is ₹64.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹19.00 Cr. (Mar 2023) to ₹64.00 Cr., marking an increase of 45.00 Cr..
For CWIP, as of Mar 2024, the value is ₹0.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹47.00 Cr. (Mar 2023) to ₹0.00 Cr., marking a decrease of 47.00 Cr..
For Investments, as of Mar 2024, the value is ₹1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2023) which recorded ₹1.00 Cr..
For Other Assets, as of Mar 2024, the value is ₹110.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹70.00 Cr. (Mar 2023) to ₹110.00 Cr., marking an increase of 40.00 Cr..
For Total Assets, as of Mar 2024, the value is ₹176.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹137.00 Cr. (Mar 2023) to ₹176.00 Cr., marking an increase of 39.00 Cr..

However, the Borrowings (55.00 Cr.) are higher than the Reserves (₹39.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

No data available for this post.

Free Cash Flow

Month	Mar 2011	Mar 2012	Mar 2013	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Free Cash Flow	-2.00	-5.00	-8.00	-10.00	-10.00	-11.00	-9.00	-15.00	-28.00	-47.00	-64.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2011	Mar 2012	Mar 2013	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Debtor Days	156	144	144	134	112	102	103	116	126	93	77
Inventory Days			76	48	53	70	95	102	92	75	77
Days Payable			128	111	129	131	134	100	81	63	72
Cash Conversion Cycle	156	144	92	71	35	42	64	118	137	105	82
Working Capital Days	92	78	98	109	60	72	86	128	152	120	104
ROCE %		12%	18%		20%	23%	21%	15%	12%	9%	8%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2019	Mar 2020	Sep 2020	Mar 2021	Sep 2021	Nov 2021	Mar 2022	Sep 2022	Mar 2023	Sep 2023	Nov 2023	Mar 2024
Promoters	72.67%	72.67%	72.67%	72.67%	72.67%	63.59%	63.59%	63.59%	63.59%	63.59%	57.95%	57.95%
Public	27.33%	27.33%	27.34%	27.34%	27.34%	36.41%	36.42%	36.41%	36.41%	36.41%	42.04%	42.05%
No. of Shareholders	172	168	161	163	206	227	209	212	210	228	213	251

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	3.48	1.07	3.06	3.35	2.72
Diluted EPS (Rs.)	3.48	1.07	3.06	3.35	2.72
Cash EPS (Rs.)	8.32	5.34	5.32	5.38	4.34
Book Value[Excl.RevalReserv]/Share (Rs.)	65.65	49.70	47.69	36.49	33.14
Book Value[Incl.RevalReserv]/Share (Rs.)	65.65	49.70	47.69	36.49	33.14
Revenue From Operations / Share (Rs.)	193.63	206.42	195.94	170.65	143.49
PBDIT / Share (Rs.)	7.23	13.51	11.51	12.99	11.04
PBIT / Share (Rs.)	3.23	11.24	9.31	10.96	9.42
PBT / Share (Rs.)	-10.05	4.69	4.36	5.14	4.50
Net Profit / Share (Rs.)	4.31	3.07	3.13	3.35	2.72
NP After MI And SOA / Share (Rs.)	4.31	3.07	3.13	3.35	2.72
PBDIT Margin (%)	3.73	6.54	5.87	7.61	7.69
PBIT Margin (%)	1.66	5.44	4.75	6.42	6.56
PBT Margin (%)	-5.19	2.27	2.22	3.01	3.13
Net Profit Margin (%)	2.22	1.48	1.59	1.96	1.89
NP After MI And SOA Margin (%)	2.22	1.48	1.59	1.96	1.89
Return on Networth / Equity (%)	6.56	6.18	6.55	9.18	8.21
Return on Capital Employeed (%)	2.74	10.23	10.50	16.54	17.38
Return On Assets (%)	1.73	1.43	1.79	2.18	2.21
Long Term Debt / Equity (X)	0.50	0.73	0.37	0.32	0.11
Total Debt / Equity (X)	1.19	2.09	1.54	1.70	1.14
Asset Turnover Ratio (%)	0.87	1.06	1.33	1.23	1.17
Current Ratio (X)	1.15	1.01	1.30	1.27	1.31
Quick Ratio (X)	0.83	0.66	0.91	0.86	0.84
Inventory Turnover Ratio (X)	4.29	5.17	5.06	4.34	3.67
Interest Coverage Ratio (X)	0.75	2.08	2.32	2.19	2.37
Interest Coverage Ratio (Post Tax) (X)	0.75	1.48	1.63	1.55	1.64
Enterprise Value (Cr.)	126.46	118.61	112.99	51.85	47.72
EV / Net Operating Revenue (X)	0.92	0.89	0.89	0.59	0.65
EV / EBITDA (X)	24.77	13.65	15.26	7.86	8.51
MarketCap / Net Operating Revenue (X)	0.53	0.39	0.56	0.26	0.42
Price / BV (X)	1.57	1.63	2.31	1.26	1.85
Price / Net Operating Revenue (X)	0.53	0.39	0.56	0.26	0.42
EarningsYield	0.04	0.03	0.02	0.07	0.04

After reviewing the key financial ratios for Ambani Organics Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 24, the value is 3.48. This value is below the healthy minimum of 5. It has increased from 1.07 (Mar 23) to 3.48, marking an increase of 2.41.
For Diluted EPS (Rs.), as of Mar 24, the value is 3.48. This value is below the healthy minimum of 5. It has increased from 1.07 (Mar 23) to 3.48, marking an increase of 2.41.
For Cash EPS (Rs.), as of Mar 24, the value is 8.32. This value is within the healthy range. It has increased from 5.34 (Mar 23) to 8.32, marking an increase of 2.98.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 65.65. It has increased from 49.70 (Mar 23) to 65.65, marking an increase of 15.95.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 65.65. It has increased from 49.70 (Mar 23) to 65.65, marking an increase of 15.95.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 193.63. It has decreased from 206.42 (Mar 23) to 193.63, marking a decrease of 12.79.
For PBDIT / Share (Rs.), as of Mar 24, the value is 7.23. This value is within the healthy range. It has decreased from 13.51 (Mar 23) to 7.23, marking a decrease of 6.28.
For PBIT / Share (Rs.), as of Mar 24, the value is 3.23. This value is within the healthy range. It has decreased from 11.24 (Mar 23) to 3.23, marking a decrease of 8.01.
For PBT / Share (Rs.), as of Mar 24, the value is -10.05. This value is below the healthy minimum of 0. It has decreased from 4.69 (Mar 23) to -10.05, marking a decrease of 14.74.
For Net Profit / Share (Rs.), as of Mar 24, the value is 4.31. This value is within the healthy range. It has increased from 3.07 (Mar 23) to 4.31, marking an increase of 1.24.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 4.31. This value is within the healthy range. It has increased from 3.07 (Mar 23) to 4.31, marking an increase of 1.24.
For PBDIT Margin (%), as of Mar 24, the value is 3.73. This value is below the healthy minimum of 10. It has decreased from 6.54 (Mar 23) to 3.73, marking a decrease of 2.81.
For PBIT Margin (%), as of Mar 24, the value is 1.66. This value is below the healthy minimum of 10. It has decreased from 5.44 (Mar 23) to 1.66, marking a decrease of 3.78.
For PBT Margin (%), as of Mar 24, the value is -5.19. This value is below the healthy minimum of 10. It has decreased from 2.27 (Mar 23) to -5.19, marking a decrease of 7.46.
For Net Profit Margin (%), as of Mar 24, the value is 2.22. This value is below the healthy minimum of 5. It has increased from 1.48 (Mar 23) to 2.22, marking an increase of 0.74.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 2.22. This value is below the healthy minimum of 8. It has increased from 1.48 (Mar 23) to 2.22, marking an increase of 0.74.
For Return on Networth / Equity (%), as of Mar 24, the value is 6.56. This value is below the healthy minimum of 15. It has increased from 6.18 (Mar 23) to 6.56, marking an increase of 0.38.
For Return on Capital Employeed (%), as of Mar 24, the value is 2.74. This value is below the healthy minimum of 10. It has decreased from 10.23 (Mar 23) to 2.74, marking a decrease of 7.49.
For Return On Assets (%), as of Mar 24, the value is 1.73. This value is below the healthy minimum of 5. It has increased from 1.43 (Mar 23) to 1.73, marking an increase of 0.30.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.50. This value is within the healthy range. It has decreased from 0.73 (Mar 23) to 0.50, marking a decrease of 0.23.
For Total Debt / Equity (X), as of Mar 24, the value is 1.19. This value exceeds the healthy maximum of 1. It has decreased from 2.09 (Mar 23) to 1.19, marking a decrease of 0.90.
For Asset Turnover Ratio (%), as of Mar 24, the value is 0.87. It has decreased from 1.06 (Mar 23) to 0.87, marking a decrease of 0.19.
For Current Ratio (X), as of Mar 24, the value is 1.15. This value is below the healthy minimum of 1.5. It has increased from 1.01 (Mar 23) to 1.15, marking an increase of 0.14.
For Quick Ratio (X), as of Mar 24, the value is 0.83. This value is below the healthy minimum of 1. It has increased from 0.66 (Mar 23) to 0.83, marking an increase of 0.17.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 4.29. This value is within the healthy range. It has decreased from 5.17 (Mar 23) to 4.29, marking a decrease of 0.88.
For Interest Coverage Ratio (X), as of Mar 24, the value is 0.75. This value is below the healthy minimum of 3. It has decreased from 2.08 (Mar 23) to 0.75, marking a decrease of 1.33.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 0.75. This value is below the healthy minimum of 3. It has decreased from 1.48 (Mar 23) to 0.75, marking a decrease of 0.73.
For Enterprise Value (Cr.), as of Mar 24, the value is 126.46. It has increased from 118.61 (Mar 23) to 126.46, marking an increase of 7.85.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.92. This value is below the healthy minimum of 1. It has increased from 0.89 (Mar 23) to 0.92, marking an increase of 0.03.
For EV / EBITDA (X), as of Mar 24, the value is 24.77. This value exceeds the healthy maximum of 15. It has increased from 13.65 (Mar 23) to 24.77, marking an increase of 11.12.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.53. This value is below the healthy minimum of 1. It has increased from 0.39 (Mar 23) to 0.53, marking an increase of 0.14.
For Price / BV (X), as of Mar 24, the value is 1.57. This value is within the healthy range. It has decreased from 1.63 (Mar 23) to 1.57, marking a decrease of 0.06.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.53. This value is below the healthy minimum of 1. It has increased from 0.39 (Mar 23) to 0.53, marking an increase of 0.14.
For EarningsYield, as of Mar 24, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 23) to 0.04, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Ambani Organics Ltd as of March 24, 2025 is: ₹48.69

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of March 24, 2025, Ambani Organics Ltd is Overvalued by 51.31% compared to the current share price 100.00

Default values used*: Default value of 15 for Stock P/E is used

Intrinsic Value of Ambani Organics Ltd as of March 24, 2025 is: 43.99

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of March 24, 2025, Ambani Organics Ltd is Overvalued by 56.01% compared to the current share price 100.00

Default values used*: Default value of 15 for Stock P/E is used

Last 5 Year EPS CAGR: -9.65%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The company has shown consistent growth in sales (69.75 cr) and profit (1.75 cr) over the years.	The stock has a low average ROCE of 12.55%, which may not be favorable. The stock has a high average Working Capital Days of 99.91, which may not be favorable. The stock has a high average Cash Conversion Cycle of 95.09, which may not be favorable. The company has higher borrowings (25.83) compared to reserves (11.00), which may suggest financial risk.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Ambani Organics Ltd:
1. Net Profit Margin: 2.22%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 2.74% (Industry Average ROCE: 15.97%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 6.56% (Industry Average ROE: 12.07%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 0.75
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 0.83
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 0 (Industry average Stock P/E: 58.92)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 1.19
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

No data availabale for About the Company

INDUSTRY	ADDRESS	CONTACT
Industry not found	Address not found	Contact not found

Management Data not Available

FAQ

What is the latest intrinsic value of Ambani Organics Ltd?

The latest intrinsic value of Ambani Organics Ltd as on 06 February 2025 is ₹48.69, which is 51.31% lower than the current market price of ₹100.00, indicating the stock is overvalued by 51.31%. The stock has a market capitalization of 70.6 Cr. and recorded a high/low of 163/93.3 during the current fiscal year 2024-2025. As of Mar 2024, the company has reserves of ₹39 Cr and total liabilities of 176 Cr.

What is the Market Cap of Ambani Organics Ltd?

The Market Cap of Ambani Organics Ltd is 70.6 Cr..

What is the current Stock Price of Ambani Organics Ltd as on 06 February 2025?

The current stock price of Ambani Organics Ltd as on 06 February 2025 is 100.

What is the High / Low of Ambani Organics Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of Ambani Organics Ltd stocks is 163/93.3.

What is the Stock P/E of Ambani Organics Ltd?

The Stock P/E of Ambani Organics Ltd is .

What is the Book Value of Ambani Organics Ltd?

The Book Value of Ambani Organics Ltd is 73.8.

What is the Dividend Yield of Ambani Organics Ltd?

The Dividend Yield of Ambani Organics Ltd is 0.00 %.

What is the ROCE of Ambani Organics Ltd?

The ROCE of Ambani Organics Ltd is 2.12 %.

What is the ROE of Ambani Organics Ltd?

The ROE of Ambani Organics Ltd is 5.39 %.

What is the Face Value of Ambani Organics Ltd?

The Face Value of Ambani Organics Ltd is 10.0.